Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its incidence increases with age. Current data suggest that anticoagulation with warfarin or dabigatran is far superior to ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study.

Primary non-adherence was highest with dabigatran (7.8%) and lowest (2.7% ... Despite proven efficacy for stroke prevention in atrial fibrillation, adherence and persistence are suboptimal for oral ...